JBS NV is a protein food company, selling protein products, which include fresh and frozen cuts of beef, pork, lamb, fish, whole chickens, and chicken parts, to retailers, and foodservice companies... Show more
JBS S.A. is the world's largest meat-processing company, operating an integrated platform that spans beef, pork, poultry, and diversified value-added products across more than 250 facilities and over 180 countries. This scale and geographic breadth represent the company's core structural advantage: rather than depending on a single protein or region, JBS can reallocate capital and commercial focus toward whichever market is strongest at a given point in the cycle.
The strategic picture is nuanced heading into 2026. The North American beef business — historically a pillar of profitability — is navigating one of the tightest U.S. cattle supplies in decades, which has pushed that segment's margins into negative territory. Meanwhile, higher-growth and higher-margin operations such as Seara (prepared and processed foods in Brazil), JBS Australia, and branded U.S. pork and poultry products are compensating. This is why management frames diversification as its primary buffer against commodity cycles.
Looking ahead, the medium-term thesis rests on two pillars: first, a cyclical recovery in U.S. beef as herd rebuilding progresses and cross-border cattle flows normalize; second, continued expansion into value-added and prepared foods, which carry more stable margins than commodity meat. A planned leadership transition — Wesley Batista Filho is set to become global CEO in January 2027 — introduces execution continuity at a moment when capital allocation discipline will be closely scrutinized.
Several developments could reshape investor sentiment over the coming quarters. The most consequential is the gradual reopening of the Mexico–U.S. border for cattle. Analysts at JPMorgan have cited this as a potential inflection point for the sector, estimating that each one-percentage-point improvement in U.S. beef EBITDA margin could lift JBS's consolidated EBITDA by roughly 4.6%.
China's import quota is a second key variable. With China capping Brazilian beef imports at just over one million tonnes annually and applying a prohibitive tariff above that threshold, JBS must redirect volumes to alternative markets. Management has indicated shipments should resume around November 2026, with clearer visibility in 2027.
Other catalysts include quarterly earnings releases, where investors will focus on free-cash-flow recovery and leverage trends; ongoing capital allocation decisions, including a $1.00-per-share dividend and a multi-billion-dollar annual capex (capital expenditure) program aimed at modernizing facilities and expanding higher-margin segments; and potential M&A (mergers and acquisitions) in Europe and the Middle East.
On the analyst front, sentiment is constructive but measured. The consensus rating is a "Moderate Buy," with an average 12-month price target near $18.50 (high $20.00, low $17.00). JPMorgan holds an Overweight rating with an $18.00 target, UBS is at Buy with $17.50, Barclays maintains Overweight, and Goldman Sachs reaffirmed Buy. Notably, some targets have been trimmed from earlier levels, reflecting near-term margin pressure rather than a loss of conviction in the long-term story.
JBS operates at the intersection of several macro currents. Interest rates matter less directly than for financials, but elevated borrowing costs raise the burden of its net debt, currently around $17–18 billion, and influence its cost of capital. Inflation and consumer demand cycles shape volumes directly: U.S. pork, for example, skews toward lower-income consumers who trade down when budgets tighten, while premium branded products have shown resilience.
Commodity prices are the dominant swing factor. Grain prices influence poultry and pork feed costs, cattle prices determine beef margins, and energy costs ripple through logistics. Geopolitical tension in the Middle East has added freight costs without interrupting shipments. On the regulatory and trade front, tariffs, import quotas, disease-outbreak protocols, and animal-health rules — such as avian influenza — can rapidly alter supply and demand balances across borders.
A structural tailwind underpins all of this: rising global protein consumption driven by population growth and emerging-market income gains. Management and analysts alike point to this secular demand trend as the foundation for long-term volume growth, even as cyclical and macro headwinds pressure near-term margins.
The Trend Prediction Engine is an AI-powered forecasting tool designed to help traders identify whether a stock, ETF (exchange-traded fund), or other asset may trend bullish, bearish, or sideways over the next week or month. By analyzing developing price patterns, the engine aims to help users spot emerging trends, evaluate possible breakouts or reversals, and explore predictions across a broad universe of tradable instruments. The platform includes searchable prediction categories, historical context, and alert-oriented functionality to support timely decision-making. For investors tracking JBS, tools like this can complement fundamental research by adding a technical, momentum-based perspective. Explore the Trend Prediction Engine to see how AI-driven signals may inform your market view.
The 2026 outlook is best characterized as a transition year. Consensus expectations anticipate continued margin compression across most business units, with U.S. beef remaining the primary drag while the cattle cycle bottoms. The pivotal question is timing: several analysts, including XP and JPMorgan, model a shift in U.S. beef from negative to positive EBITDA as 2027 approaches, driven by reduced slaughter capacity, herd rebuilding, and restored cross-border cattle flows.
Long-term themes will define the investment case beyond 2026. Market expansion into Europe, the Middle East, and value-added categories should reduce earnings volatility and lift the product mix. Cost-structure evolution — through facility modernization and efficiency programs — aims to protect margins even in soft commodity environments. Technology adoption in automation and supply-chain management offers incremental efficiency gains. Meanwhile, competitive threats from global peers such as Tyson Foods, Marfrig, and BRF, plus the gradual rise of alternative proteins, warrant continued monitoring.
Capital allocation priorities will be closely watched: balancing growth capex, debt reduction toward the 3.0x net-debt-to-EBITDA target, and shareholder returns through dividends. If leverage trends down while free cash flow normalizes, analysts' constructive stance could translate into more positive target revisions; if the U.S. cattle recovery stalls, the near-term earnings pressure could persist longer than consensus currently assumes.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, JBS has been loosely correlated with PPC. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if JBS jumps, then PPC could also see price increases.
| Ticker / NAME | Correlation To JBS | 1D Price Change % |
|---|---|---|
| JBS | 100% | +6.23% |
| Food: Major Diversified industry (62 stocks) | 20% Poorly correlated | -2.98% |
Industry FoodMajorDiversified
The Moving Average Convergence Divergence (MACD) for JBS turned positive on November 04, 2026. Looking at past instances where JBS's MACD turned positive, the stock continued to rise in 33 of 43 cases over the following month. The odds of a continued upward trend are 77%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where JBS's RSI Oscillator exited the oversold zone, 16 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on JBS as a result. In 71 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
JBS moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +5.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where JBS advanced for three days, in 202 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
JBS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for JBS crossed bearishly below the 50-day moving average on October 27, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JBS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
The Aroon Indicator for JBS entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.184) is normal, around the industry mean (5.975). P/E Ratio (12.112) is within average values for comparable stocks, (7.223). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (8.458). JBS's Dividend Yield (0.309) is considerably higher than the industry average of (0.048). P/S Ratio (0.441) is also within normal values, averaging (5.003).
The Tickeron Seasonality Score of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 53 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. JBS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 67 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JBS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.